FRA
BHVN

Front Row Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Front Row Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49
Closed -$7K – 950
2022
Q2 		$7K Buy
49
+18
+58% +$2.57K ﹤0.01% 605
2022
Q1 		$4K Hold
31
– – ﹤0.01% 781
2021
Q4 		$4K Buy
+31
New +$4K ﹤0.01% 808